Phase Ib trial results for enzalutamide/CC-115 for metastatic castration-resistant prostate cancer June 26, 2018
Phase III EASE-2 and EASE-3 trials of empagliflozin in type 1 diabetes meet primary endpoint June 26, 2018
Merrimack discontinues development of MM-141 for pancreatic cancer following CARRIE results June 25, 2018
DSMB of Aladote phase Ib/IIa study to treat paracetamol poisoning finds no safety concerns June 25, 2018
RSS